Insight Molecular Diagnostics (IMDX) Goodwill (2020 - 2023)

Insight Molecular Diagnostics (IMDX) has 4 years of Goodwill data on file, last reported at $9.5 million in Q3 2023.

• Quarterly Goodwill fell 49.15% year-over-year to $9.5 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $9.5 million (down 49.15% YoY) and the FY2022 annual result came in at $9.2 million, down 50.76% from the prior year.
• Goodwill was little changed at $9.5 million in Q3 2023 per IMDX's latest filing, from $9.5 million in the prior quarter.
• The five-year high for Goodwill was $24.2 million in Q2 2021, with the low at $9.2 million in Q1 2020.
• Average Goodwill over 4 years is $13.4 million, with a median of $9.5 million recorded in 2023.
• Year-over-year, Goodwill jumped 163.82% in 2021 and tumbled 50.76% in 2022.
• Insight Molecular Diagnostics' Goodwill stood at $9.2 million in 2020, then soared by 103.37% to $18.7 million in 2021, then slumped by 50.76% to $9.2 million in 2022, then grew by 3.26% to $9.5 million in 2023.
• Business Quant data shows IMDX's Goodwill at $9.5 million in Q3 2023, $9.5 million in Q2 2023, and $9.5 million in Q1 2023.